Emerging role of autophagy in kidney function, diseases and aging

Autophagy

Volumn 8, Issue 7, 2012, Pages 1009-1031

  Huber, Tobias B ^a,b   Edelstein, Charles L ^c   Hartleben, Björn ^a   Inoki, Ken ^d   Jiang, Man ^e   Koya, Daisuke ^f   Kume, Shinji ^g   Lieberthal, Wilfred ^h   Pallet, Nicolas ⁱ   Quiroga, Alejandro ^j   Ravichandran, Kameswaran ^c   Susztak, Katalin ^j   Yoshida, Sei ^d   Dong, Zheng ^e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

^f KANAZAWA MEDICAL UNIVERSITY   (Japan)

^g SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^h STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Acute kidney injury; Aging; Autophagy; Glomerulus; Kidney; Kidney transplantation; mTOR; Podocyte; Polycystic kidney disease

Indexed keywords

ALPHA SYNUCLEIN; BECLIN 1; CYCLOSPORIN A; ENZYME INHIBITOR; INSULIN RECEPTOR SUBSTRATE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MITOGEN ACTIVATED PROTEIN KINASE 3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEPHRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PODOCIN; PROTEIN KINASE B; PROTEIN P53; RAPAMYCIN; RIBONUCLEASE A; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SPHINGOSINE KINASE INHIBITOR; TACROLIMUS; TRANSCRIPTION FACTOR PAX2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; AGING; APOPTOSIS; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CAENORHABDITIS ELEGANS; CELL DIFFERENTIATION; CELL MATURATION; COLD ISCHEMIA; DIABETIC NEPHROPATHY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; GOLGI COMPLEX; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; MACROAUTOPHAGY; NEPHROTIC SYNDROME; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PODOCYTE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

EID: 84866142024     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.19821     Document Type: Review

References (268)

1. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451:1069-75; PMID:18305538; http://dx.doi.org/10.1038/nature06639
2. Rubinsztein DC. The roles of intracellular proteindegradation pathways in neurodegeneration. Nature 2006; 443:780-6; PMID:17051204; http://dx.doi.org/ 10.1038/nature05291
3. Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12:814-22; PMID:20811353; http://dx.doi.org/10.1038/ncb0910- 814
4. Weide T, Huber TB. Implications of autophagy for glomerular aging and disease. Cell Tissue Res 2011; 343:467-73; PMID:21286756; http://dx.doi.org/10. 1007/s00441-010-1115-0
5. Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol 2010; 12:823-30; PMID:20811354; http://dx.doi.org/10. 1038/ncb0910-823
6. Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA, Hall A, et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6:1122-8; PMID:15467718; http:// dx.doi.org/10.1038/ncb1183
7. Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 2002; 10:457- 68; PMID:12408816; http://dx.doi.org/10.1016/ S1097-2765(02)00636-6
8. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycininsensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004; 14:1296- 302; PMID:15268862; http://dx.doi.org/10.1016/j. cub.2004.06.054
9. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002; 110:177-89; PMID:12150926; http://dx.doi.org/10. 1016/S0092-8674(02)00833-4
10. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002; 110:163-75; PMID:12150925; http://dx.doi.org/10.1016/S0092- 8674(02)00808-5
11. Kim D-H, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H, et al. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 2003; 11:895-904; PMID: 12718876; http://dx.doi.org/10.1016/S1097-2765 (03)00114-X
12. Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 2009; 137:873-86; PMID:19446321; http://dx.doi.org/10. 1016/j.cell.2009.03.046
13. Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 2007; 25:903-15; PMID:17386266; http:// dx.doi.org/10.1016/j.molcel.2007. 03.003
14. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH. Insulin signalling to mTOR mediated by the Akt/ PKB substrate PRAS40. Nat Cell Biol 2007; 9:316-23; PMID:17277771; http://dx.doi.org/10.1038/ncb1547
15. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18:1926-45; PMID: 15314020; http://dx.doi.org/10.1101/gad.1212704
16. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 2010; 40:310-22; PMID: 20965424; http://dx.doi.org/10.1016/j.molcel.2010. 09.026
17. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471-84; PMID:16469695; http://dx.doi.org/10.1016/j. cell. 2006.01.016
18. Burnett PE, Barrow RK, Cohen NA, Snyder SH, Sabatini DM. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci U S A 1998; 95:1432-7; PMID: 9465032; http://dx.doi.org/10.1073/ pnas.95.4.1432
19. Ganley IG, Lam H, Wang J, Ding X, Chen S, Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 2009; 284:12297-305; PMID:19258318; http://dx. doi.org/10.1074/jbc.M900573200
20. Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20:1981- 91; PMID:19211835; http://dx.doi.org/10.1091/mbc. E08-12-1248
21. Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D, et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011; 332:1317-22; PMID:21659604; http://dx.doi.org/10.1126/science. 1199498
22. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20:1992-2003; PMID:19225151; http://dx.doi.org/10.1091/mbc.E08-12-1249
23. Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011; 146:408-20; PMID:21816276; http://dx.doi. org/10.1016/j.cell.2011.06. 034
24. Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, Villén J, et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011; 332:1322-6; PMID:21659605; http://dx.doi.org/10.1126/science. 1199484
25. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12:21-35; PMID:21157483; http://dx.doi.org/10.1038/nrm3025
26. Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H, et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 2004; 166:213-23; PMID:15249583; http://dx.doi.org/10.1083/jcb. 200403069
27. Shah OJ, Wang Z, Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 2004; 14:1650-6; PMID:15380067; http://dx.doi.org/10.1016/j.cub.2004.08.026
28. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004; 431:200-5; PMID: 15306821; http://dx.doi.org/10.1038/nature02866
29. Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, Carr SA, et al. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 2006; 16:1865-70; PMID: 16919458; http://dx.doi.org/10.1016/j.cub.2006.08. 001
30. Thedieck K, Polak P, Kim ML, Molle KD, Cohen A, Jenö P, et al. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS One 2007; 2:e1217; PMID:18030348; http://dx.doi.org/ 10.1371/journal.pone. 0001217
31. Woo SY, Kim DH, Jun CB, Kim YM, Haar EV, Lee SI, et al. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. J Biol Chem 2007; 282:25604-12; PMID:17599906; http://dx.doi.org/ 10.1074/jbc.M704343200
32. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307:1098-101; PMID:15718470; http://dx.doi.org/10.1126/science. 1106148
33. Zinzalla V, Stracka D, Oppliger W, Hall MN. Activation of mTORC2 by association with the ribosome. Cell 2011; 144:757-68; PMID:21376236; http://dx.doi.org/10.1016/j.cell.2011.02.014
34. Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 2003; 11:1457-66; PMID:12820960; http://dx.doi.org/10.1016/S1097- 2765(03)00220-X
35. Inoki K, Li Y, Xu T, Guan K-L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003; 17:1829-34; PMID:12869586; http://dx.doi.org/10.1101/gad. 1110003
36. Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL. Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 2008; 10:935-45; PMID:18604198; http://dx.doi.org/10.1038/ncb1753
37. Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008; 320:1496-501; PMID:18497260; http:// dx.doi.org/10.1126/science. 1157535
38. Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 2003; 13:1259-68; PMID:12906785; http://dx. doi.org/10.1016/S0960-9822(03)00506-2
39. Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 2003; 5:578-81; PMID:12771962; http://dx.doi.org/10.1038/ncb999
40. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010; 141:290- 303; PMID:20381137; http://dx.doi.org/10.1016/j. cell.2010.02.024
41. Sekiguchi T, Hirose E, Nakashima N, Ii M, Nishimoto T. Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B. J Biol Chem 2001; 276:7246-57; PMID:11073942; http://dx.doi.org/10.1074/jbc.M004389200
42. Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J. Rheb binds and regulates the mTOR kinase. Curr Biol 2005; 15:702-13; PMID:15854902; http://dx.doi.org/ 10.1016/j.cub.2005.02.053
43. Oshiro N, Takahashi R, Yoshino K, Tanimura K, Nakashima A, Eguchi S, et al. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J Biol Chem 2007; 282:20329-39; PMID:17517883; http://dx.doi.org/10.1074/jbc.M702636200
44. Castro AF, Rebhun JF, Clark GJ, Quilliam LA. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem 2003; 278:32493-6; PMID:12842888; http://dx.doi.org/10. 1074/jbc.C300226200
45. Saucedo LJ, Gao X, Chiarelli DA, Li L, Pan D, Edgar BA. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol 2003; 5:566-71; PMID:12766776; http://dx.doi.org/10. 1038/ncb996
46. Inoki K, Li Y, Zhu T, Wu J, Guan K-L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002; 4:648-57; PMID:12172553; http://dx.doi.org/10.1038/ncb839
47. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 2005; 121:179-93; PMID:15851026; http://dx.doi.org/10.1016/j.cell. 2005.02.031
48. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 2002; 10:151-62; PMID:12150915; http:// dx.doi.org/10.1016/S1097-2765(02)00568-3
49. Jung CH, Ro SH, Cao J, Otto NM, Kim DH. mTOR regulation of autophagy. FEBS Lett 2010; 584:1287- 95; PMID:20083114; http://dx.doi.org/10.1016/j. febslet.2010.01.017
50. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol 2000; 150:1507-13; PMID:10995454; http://dx. doi.org/10.1083/jcb.150.6.1507
51. Matsuura A, Tsukada M, Wada Y, Ohsumi Y. Apg1p, a novel protein kinase required for the autophagic process in Saccharomyces cerevisiae . Gene 1997; 192:245-50; PMID:9224897; http://dx.doi.org/10. 1016/S0378-1119(97)00084-X
52. Kabeya Y, Kamada Y, Baba M, Takikawa H, Sasaki M, Ohsumi Y. Atg17 functions in cooperation with Atg1 and Atg13 in yeast autophagy. Mol Biol Cell 2005; 16:2544-53; PMID:15743910; http://dx.doi.org/10. 1091/mbc.E04-08-0669
53. Kawamata T, Kamada Y, Kabeya Y, Sekito T, Ohsumi Y. Organization of the pre-autophagosomal structure responsible for autophagosome formation. Mol Biol Cell 2008; 19:2039-50; PMID:18287526; http://dx. doi.org/10.1091/mbc.E07-10-1048
54. Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol 2011; 23:744-55; PMID:21963299; http://dx.doi.org/10.1016/j.ceb.2011.09.003
55. Lieberthal W, Levine JS. The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol 2009; 20:2493-502; PMID:19875810; http://dx.doi.org/10.1681/ASN.2008111186
56. 2009 Annual Data Report Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. United States Renal Data System http://www. usrds.org, 2009:231-9.
57. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99:342-8; PMID:9006003; http://dx.doi. org/10.1172/JCI119163
58. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002; 61:1475-85; PMID:11918755; http://dx.doi.org/10.1046/j.1523- 1755.2002.00269.x
59. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, Piras G, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002; 51:3083-9; PMID:12351451; http://dx. doi.org/10.2337/diabetes.51. 10.3083
60. Huber TB, Walz G, Kuehn EW. mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression. Kidney Int 2011; 79:502-11; PMID:21085109; http://dx.doi.org/ 10.1038/ki.2010.457
61. Lloberas N, Cruzado JM, Franquesa M, Herrero- Fresneda I, Torras J, Alperovich G, et al. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol 2006; 17:1395-404; PMID:16597691; http://dx.doi.org/10.1681/ASN.2005050549
62. Nagai K, Matsubara T, Mima A, Sumi E, Kanamori H, Iehara N, et al. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int 2005; 68:552-61; PMID:16014032; http://dx.doi.org/10.1111/j.1523-1755.2005. 00433.x
63. Sataranatarajan K, Mariappan MM, Lee MJ, Feliers D, Choudhury GG, Barnes JL, et al. Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin. Am J Pathol 2007; 171:1733-42; PMID:17991718; http://dx.doi. org/10.2353/ajpath.2007.070412
64. Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, et al. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol 2007; 27:495-502; PMID:17671379; http://dx.doi. org/10.1159/000106782
65. Gödel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 2011; 121:2197-209; PMID:21606591; http:// dx.doi.org/10.1172/ JCI44774
66. Hartleben B, Gödel M, Meyer-Schwesinger C, Liu S, Ulrich T, Köbler S, et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010; 120:1084-96; PMID:20200449; http://dx.doi.org/10. 1172/JCI39492
67. Inoki K, Mori H, Wang J, Suzuki T, Hong S, Yoshida S, et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 2011; 121:2181-96; PMID: 21606597; http://dx.doi.org/10.1172/JCI44771
68. Asanuma K, Tanida I, Shirato I, Ueno T, Takahara H, Nishitani T, et al. MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J 2003; 17:1165-7; PMID:12709412
69. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004; 15:1101-11; PMID:14699058; http://dx.doi. org/10.1091/mbc.E03-09-0704
70. Sato S, Kitamura H, Adachi A, Sasaki Y, Ghazizadeh M. Two types of autophagy in the podocytes in renal biopsy specimens: ultrastructural study. J Submicrosc Cytol Pathol 2006; 38:167-74; PMID:17784646
71. Narita M, Young AR, Arakawa S, Samarajiwa SA, Nakashima T, Yoshida S, et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 2011; 332:966-70; PMID:21512002; http://dx.doi.org/10.1126/science. 1205407
72. Young AR, Narita M, Narita M. Spatio-temporal association between mTOR and autophagy during cellular senescence. Autophagy 2011; 7:1387-8; PMID:21799306; http://dx.doi.org/10.4161/auto.7. 11.17348
73. Eremina V, Baelde HJ, Quaggin SE. Role of the VEGF-a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron, Physiol 2007; 106:32-7; http://dx.doi.org/10.1159/ 000101798
74. Simons M, Saffrich R, Reiser J, Mundel P. Directed membrane transport is involved in process formation in cultured podocytes. J Am Soc Nephrol 1999; 10:1633-9; PMID:10446930
75. Cuervo AM. Autophagy: many paths to the same end. Mol Cell Biochem 2004; 263:55-72; PMID: 15524167; http://dx.doi.org/10.1023/B:MCBI. 0000041848.57020.57
76. Kon M, Cuervo AM. Chaperone-mediated autophagy in health and disease. FEBS Lett 2010; 584:1399-404; PMID:20026330; http://dx.doi.org/10.1016/j. febslet. 2009.12.025
77. Dice JF. Chaperone-mediated autophagy. Autophagy 2007; 3:295-9; PMID:17404494
78. Massey AC, Kaushik S, Sovak G, Kiffin R, Cuervo AM. Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci U S A 2006; 103:5805-10; PMID:16585521; http:// dx.doi.org/10.1073/pnas.0507436103
79. Kaushik S, Massey AC, Mizushima N, Cuervo AM. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol Biol Cell 2008; 19:2179-92; PMID:18337468; http:// dx.doi.org/10.1091/mbc.E07-11-1155
80. Cuervo AM, Knecht E, Terlecky SR, Dice JF. Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am J Physiol 1995; 269:C1200-8; PMID:7491910
81. Kiffin R, Christian C, Knecht E, Cuervo AM. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 2004; 15:4829-40; PMID:15331765; http://dx.doi.org/10.1091/mbc. E04-06-0477
82. Cuervo AM, Bergamini E, Brunk UT, Dröge W, Ffrench M, Terman A. Autophagy and aging: the importance of maintaining "clean" cells. Autophagy 2005; 1:131-40; PMID:16874025; http://dx.doi.org/ 10.4161/auto.1.3. 2017
83. Chiang HL, Terlecky SR, Plant CP, Dice JF. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science 1989; 246:382-5; PMID:2799391; http://dx.doi.org/10. 1126/science.2799391
84. Bandyopadhyay U, Kaushik S, Varticovski L, Cuervo AM. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol 2008; 28:5747- 63; PMID:18644871; http://dx.doi.org/10.1128/ MCB.02070-07
85. Kaushik S, Bandyopadhyay U, Sridhar S, Kiffin R, Martinez-Vicente M, Kon M, et al. Chaperonemediated autophagy at a glance. J Cell Sci 2011; 124:495-9; PMID:21282471; http://dx.doi.org/10. 1242/jcs.073874
86. Salvador N, Aguado C, Horst M, Knecht E. Import of a cytosolic protein into lysosomes by chaperonemediated autophagy depends on its folding state. J Biol Chem 2000; 275:27447-56; PMID:10862611
87. Wing SS, Chiang HL, Goldberg AL, Dice JF. Proteins containing peptide sequences related to Lys-Phe-Glu- Arg-Gln are selectively depleted in liver and heart, but not skeletal muscle, of fasted rats. Biochem J 1991; 275:165-9; PMID:2018472
88. Cuervo AM, Terlecky SR, Dice JF, Knecht E. Selective binding and uptake of ribonuclease A and glyceralde-hyde- 3-phosphate dehydrogenase by isolated rat liver lysosomes. J Biol Chem 1994; 269:26374-80; PMID: 7929357
89. Yang Q, She H, Gearing M, Colla E, Lee M, Shacka JJ, et al. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009; 323:124-7; PMID:19119233; http://dx.doi.org/10. 1126/science.1166088
90. Lee HJ, Khoshaghideh F, Patel S, Lee SJ. Clearance of a-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 2004; 24:1888-96; PMID:14985429; http://dx.doi.org/10. 1523/JNEUROSCI.3809-03.2004
91. Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H, et al. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 2011; 42:719-30; PMID:21700219; http://dx.doi.org/10. 1016/j.molcel.2011.04.025
92. Cuervo AM, Dice JF. Regulation of lamp2a levels in the lysosomal membrane. Traffic 2000; 1:570-83; PMID:11208145; http://dx.doi.org/10.1034/j. 1600- 0854.2000.010707.x
93. Sooparb S, Price SR, Shaoguang J, Franch HA. Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int 2004; 65:2135-44; PMID:15149326; http://dx.doi. org/10.1111/j.1523- 1755.2004.00639.x
94. Han K, Zhou H, Pfeifer U. Inhibition and restimulation by insulin of cellular autophagy in distal tubular cells of the kidney in early diabetic rats. Kidney Blood Press Res 1997; 20:258-63; PMID:9398032; http:// dx.doi.org/10.1159/000174155
95. Cuervo AM, Hildebrand H, Bomhard EM, Dice JF. Direct lysosomal uptake of a 2-microglobulin contributes to chemically induced nephropathy. Kidney Int 1999; 55:529-45; PMID:9987077; http://dx.doi. org/10.1046/j.1523-1755.1999. 00268.x
96. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14:2199-210; PMID:12874476; http:// dx.doi.org/10.1097/01.ASN.0000079785.13922.F6
97. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114:5-14; PMID:15232604
98. Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 2011; 7:189-200; PMID:21364518; http://dx.doi.org/10. 1038/nrneph.2011.16
99. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17:1503-20; PMID:16707563; http://dx.doi.org/10.1681/ASN. 2006010017
100. American Society of Nephrology. American Society of Nephrology Renal Research Report. J Am Soc Nephrol 2005; 16:1886-903; PMID:15888557; http://dx.doi. org/10.1681/ASN.2005030285
101. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006; 17:1135-42; PMID:16495381; http://dx.doi.org/10. 1681/ASN.2005060668
102. Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006; 17:1143-50; PMID:16495376; http://dx.doi. org/10.1681/ASN.2005091017
103. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 2008; 48:463-93; PMID:17937594; http://dx.doi.org/ 10.1146/annurev.pharmtox.48.113006.094615
104. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008; 73:994-1007; PMID:18272962; http://dx.doi.org/10. 1038/sj.ki.5002786
105. Lieberthal W, Nigam SK. Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol 1998; 275:F623-31; PMID: 9815122
106. Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 2000; 278:F1-12; PMID:10644651
107. Chien CT, Shyue SK, Lai MK. Bcl-xL augmentation potentially reduces ischemia/reperfusion induced proximal and distal tubular apoptosis and autophagy. Transplantation 2007; 84:1183-90; PMID:17998875; http://dx.doi.org/ 10.1097/01.tp.0000287334.38933.e3
108. Wu HH, Hsiao TY, Chien CT, Lai MK. Ischemic conditioning by short periods of reperfusion attenuates renal ischemia/reperfusion induced apoptosis and autophagy in the rat. J Biomed Sci 2009; 16:19; PMID:19272187; http://dx.doi.org/10.1186/1423- 0127-16-19
109. Suzuki C, Isaka Y, Takabatake Y, Tanaka H, Koike M, Shibata M, et al. Participation of autophagy in renal ischemia/reperfusion injury. Biochem Biophys Res Commun 2008; 368:100-6; PMID:18222169; http://dx.doi.org/10.1016/j.bbrc. 2008.01.059
110. Jiang M, Liu K, Luo J, Dong Z. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol 2010; 176:1181-92; PMID:20075199; http://dx.doi.org/10. 2353/ajpath.2010.090594
111. Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macroautophagy protects against ischemia/ reperfusion injury in cardiac myocytes. J Biol Chem 2006; 281:29776-87; PMID:16882669; http://dx.doi. org/10.1074/jbc.M603783200
112. Inoue K, Kuwana H, Shimamura Y, Ogata K, Taniguchi Y, Kagawa T, et al. Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo. Clin Exp Nephrol 2010; 14:112-22; PMID:20013139; http://dx.doi.org/10. 1007/s10157- 009-0254-7
113. Kimura T, Takabatake Y, Takahashi A, Kaimori JY, Matsui I, Namba T, et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol 2011; 22:902-13; PMID: 21493778; http://dx.doi.org/10. 1681/ASN.2010070705
114. Liu S, Hartleben B, Kretz O, Wiech T, Igarashi T, Mizushima N, et al. Autophagy plays a critical role in kidney tubule maintenance, aging and ischemiareperfusion injury. Autophagy 2012; 8:826-37; PMID: 22617445; http://dx.doi.org/10.4161/auto.19419
115. Periyasamy-Thandavan S, Jiang M, Wei Q, Smith R, Yin XM, Dong Z. Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int 2008; 74:631-40; PMID:18509315; http://dx.doi. org/10.1038/ki.2008.214
116. Yang C, Kaushal V, Shah SV, Kaushal GP. Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Renal Physiol 2008; 294:F777-87; PMID:18256309; http://dx.doi. org/10.1152/ajprenal.00590.2007
117. Pallet N, Bouvier N, Legendre C, Gilleron J, Codogno P, Beaune P, et al. Autophagy protects renal tubular cells against cyclosporine toxicity. Autophagy 2008; 4:783-91; PMID:18628650
118. Chargui A, Zekri S, Jacquillet G, Rubera I, Ilie M, Belaid A, et al. Cadmium-induced autophagy in rat kidney: an early biomarker of subtoxic exposure. Toxicol Sci 2011; 121:31-42; PMID:21325019; http://dx.doi.org/10.1093/ toxsci/kfr031
119. Kimura A, Ishida Y, Wada T, Hisaoka T, Morikawa Y, Sugaya T, et al. The absence of interleukin-6 enhanced arsenite-induced renal injury by promoting autophagy of tubular epithelial cells with aberrant extracellular signal-regulated kinase activation. Am J Pathol 2010; 176:40-50; PMID:20008137; http://dx.doi.org/10. 2353/ajpath.2010.090146
120. Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010; 22:124-31; PMID:20034776; http://dx.doi.org/10.1016/j.ceb.2009.11.014
121. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009; 43:67-93; PMID:19653858; http://dx.doi.org/ 10.1146/annurev-genet-102808-114910
122. Mehrpour M, Esclatine A, Beau I, Codogno P. Overview of macroautophagy regulation in mammalian cells. Cell Res 2010; 20:748-62; PMID: 20548331; http://dx.doi.org/10.1038/cr.2010.82
123. Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010; 40:280-93; PMID:20965422; http://dx.doi.org/10.1016/j. molcel. 2010.09.023
124. Bolisetty S, Traylor AM, Kim J, Joseph R, Ricart K, Landar A, et al. Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury. J Am Soc Nephrol 2010; 21:1702-12; PMID:20705711; http://dx.doi.org/10.1681/ASN. 2010030238
125. Høyer-Hansen M, Jäättelä M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ 2007; 14:1576-82; PMID:17612585; http://dx.doi.org/10. 1038/sj.cdd.4402200
126. Gozuacik D, Bialik S, Raveh T, Mitou G, Shohat G, Sabanay H, et al. DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ 2008; 15:1875-86; PMID:18806755; http://dx.doi. org/10.1038/cdd.2008.121
127. Kawakami T, Inagi R, Takano H, Sato S, Ingelfinger JR, Fujita T, et al. Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. Nephrol Dial Transplant 2009; 24:2665-72; PMID: 19454529; http://dx.doi.org/10. 1093/ndt/gfp215
128. Kitamura M. Endoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus faces. Am J Physiol Renal Physiol 2008; 295: F323-34; PMID:18367660; http://dx.doi.org/10. 1152/ajprenal.00050.2008
129. Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A 2005; 102:8204-9; PMID: 15928081; http://dx.doi.org/10.1073/pnas.0502857102
130. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126:121-34; PMID:16839881; http://dx.doi.org/10. 1016/j.cell.2006.05.034
131. Bensaad K, Cheung EC, Vousden KH. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J 2009; 28:3015-26; PMID:19713938; http:// dx.doi.org/10.1038/emboj.2009.242
132. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M, et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 2008; 10:676-87; PMID:18454141; http://dx.doi.org/10. 1038/ncb1730
133. Isaka Y, Suzuki C, Abe T, Okumi M, Ichimaru N, Imamura R, et al. Bcl-2 protects tubular epithelial cells from ischemia/reperfusion injury by dual mechanisms. Transplant Proc 2009; 41:52-4; PMID:19249473; http://dx.doi.org/10. 1016/j.transproceed.2008.10.026
134. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122:927-39; PMID:16179260; http://dx.doi.org/10. 1016/j.cell.2005.07.002
135. Maiuri MC, Le Toumelin G, Criollo A, Rain J-C, Gautier F, Juin P, et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 2007; 26:2527-39; PMID: 17446862; http://dx.doi.org/10.1038/sj. emboj.7601689
136. Chang NC, Nguyen M, Germain M, Shore GC. Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1. EMBO J 2010; 29:606-18; PMID:20010695; http:// dx.doi.org/10.1038/emboj.2009.369
137. Høyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, Farkas T, et al. Control of macroautophagy by calcium, calmodulindependent kinase kinase-beta, and Bcl-2. Mol Cell 2007; 25:193-205; PMID:17244528; http://dx.doi. org/10.1016/j.molcel.2006.12.009
138. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 2010; 22:132-9; PMID:20056399; http://dx.doi.org/10. 1016/j.ceb.2009.12.004
139. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011; 331:456-61; PMID:21205641; http://dx.doi.org/10.1126/science. 1196371
140. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-41; PMID: 21258367; http://dx.doi.org/10.1038/ncb2152
141. Lee JW, Park S, Takahashi Y, Wang HG. The association of AMPK with ULK1 regulates autophagy. PLoS One 2010; 5:e15394; PMID:21072212; http:// dx.doi.org/10.1371/journal.pone.0015394
142. Shang L, Chen S, Du F, Li S, Zhao L, Wang X. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci U S A 2011; 108:4788-93; PMID:21383122; http:// dx.doi.org/10.1073/pnas.1100844108
143. Löffler AS, Alers S, Dieterle AM, Keppeler H, Franz- Wachtel M, Kundu M, et al. Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop. Autophagy 2011; 7:696-706; PMID: 21460634; http://dx.doi.org/10.4161/auto.7.7.15451
144. Dunlop EA, Hunt DK, Acosta-Jaquez HA, Fingar DC, Tee AR. ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding. Autophagy 2011; 7:737-47; PMID:21460630; http://dx.doi.org/ 10.4161/auto.7.7. 15491
145. Gao W, Shen Z, Shang L, Wang X. Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death. Cell Death Differ 2011; 18:1598-607; PMID:21475306; http://dx.doi.org/10.1038/cdd. 2011.33
146. Di Bartolomeo S, Corazzari M, Nazio F, Oliverio S, Lisi G, Antonioli M, et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J Cell Biol 2010; 191:155- 68; PMID:20921139; http://dx.doi.org/10.1083/jcb. 201002100
147. Takahashi A, Kimura T, Takabatake Y, Namba T, Kaimori J, Kitamura H, et al. Autophagy guards against cisplatin-induced acute kidney injury. Am J Pathol 2012; 180:517-25; PMID:22265049; http:// dx.doi.org/10.1016/j.ajpath.2011.11.001
148. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27-42; PMID:18191218; http://dx.doi.org/10.1016/j.cell.2007.12.018
149. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Selfeating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8:741-52; PMID:17717517; http://dx.doi.org/10.1038/nrm2239
150. Lee JS, Li Q, Lee JY, Lee SH, Jeong JH, Lee HR, et al. FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 2009; 11:1355-62; PMID: 19838173; http://dx.doi.org/10.1038/ncb1980
151. Hou W, Han J, Lu C, Goldstein LA, Rabinowich H. Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis. Autophagy 2010; 6:891-900; PMID:20724831; http://dx.doi.org/10.4161/auto.6.7. 13038
152. Zhou X, Zhou J, Li X, Guo C, Fang T, Chen Z. GSK- 3β inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury. Biochem Biophys Res Commun 2011; 411:271-5; PMID:21723251; http://dx.doi.org/10. 1016/j.bbrc.2011.06.117
153. Fujishima Y, Nishiumi S, Masuda A, Inoue J, Nguyen NM, Irino Y, et al. Autophagy in the intestinal epithelium reduces endotoxin-induced inflammatory responses by inhibiting NF-kB activation. Arch Biochem Biophys 2011; 506:223-35; PMID: 21156154; http://dx.doi.org/10.1016/j.abb.2010.12. 009
154. Scarlatti F, Granata R, Meijer AJ, Codogno P. Does autophagy have a license to kill mammalian cells? Cell Death Differ 2009; 16:12-20; PMID:18600232; http://dx.doi.org/10.1038/cdd.2008.101
155. Chen Y, Klionsky DJ. The regulation of autophagy- unanswered questions. J Cell Sci 2011; 124:161-70; PMID:21187343; http://dx.doi.org/10.1242/jcs.064576
156. Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 2008; 9:1004- 10; PMID:18971948; http://dx.doi.org/10.1038/ nrm2529
157. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009; 16:966-75; PMID:19325568; http://dx.doi.org/10. 1038/cdd.2009.33
158. Belibi F, Zafar I, Ravichandran K, Segvic AB, Jani A, Ljubanovic DG, et al. Hypoxia-inducible factor-1a (HIF-1a) and autophagy in polycystic kidney disease (PKD). Am J Physiol Renal Physiol 2011; 300:F1235- 43; PMID:21270095; http://dx.doi.org/10.1152/ ajprenal.00348.2010
159. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140:313- 26; PMID:20144757; http://dx.doi.org/10.1016/j. cell.2010.01.028
160. Edelstein CL. What is the role of tubular epithelial cell apoptosis in polycystic kidney disease (PKD)? Cell Cycle 2005; 4:1550-4; PMID:16258272; http://dx. doi.org/10.4161/cc.4.11.2185
161. Tao Y, Kim J, Faubel S, Wu JC, Falk SA, Schrier RW, et al. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease. Proc Natl Acad Sci U S A 2005; 102:6954-9; PMID:15863619; http://dx.doi.org/10. 1073/pnas.0408518102
162. Tao Y, Zafar I, Kim J, Schrier RW, Edelstein CL. Caspase-3 gene deletion prolongs survival in polycystic kidney disease. J Am Soc Nephrol 2008; 19:749-55; PMID:18272845; http://dx.doi.org/10.1681/ASN. 2006121378
163. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl- 2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75:229-40; PMID:8402909; http:// dx.doi.org/10.1016/0092- 8674(93)80065-M
164. Germain M, Slack RS. Dining in with BCL-2: new guests at the autophagy table. Clin Sci (Lond) 2010; 118:173-81; PMID:19845510; http://dx.doi.org/10. 1042/CS20090310
165. Saeki K, Yuo A, Okuma E, Yazaki Y, Susin SA, Kroemer G, et al. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ 2000; 7:1263- 9; PMID:11175264; http://dx.doi.org/10.1038/sj.cdd. 4400759
166. Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differ 2005; 12(Suppl 2):1528-34; PMID:16247500; http:// dx.doi.org/10.1038/sj.cdd.4401777
167. Lin HH, Yang TP, Jiang ST, Yang HY, Tang MJ. Bcl- 2 overexpression prevents apoptosis-induced Madin- Darby canine kidney simple epithelial cyst formation. Kidney Int 1999; 55:168-78; PMID:9893125; http:// dx.doi.org/10.1046/j.1523-1755.1999.00249.x
168. Bukanov NO, Smith LA, Klinger KW, Ledbetter SR, Ibraghimov-Beskrovnaya O. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 2006; 444:949-52; PMID: 17122773; http://dx.doi.org/10.1038/ nature05348
169. Zhou F, Yang Y, Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J 2011; 278:403-13; PMID: 21182587; http://dx.doi.org/10.1111/j.1742-4658. 2010.07965.x
170. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304:1500-2; PMID:15131264; http://dx.doi.org/10.1126/science. 1096645
171. Giansanti V, Torriglia A, Scovassi AI. Conversation between apoptosis and autophagy: "Is it your turn or mine?" Apoptosis 2011; 16:321-33; PMID:21404107; http://dx.doi.org/10.1007/s10495-011-0589-x
172. Kaushal GP, Kaushal V, Herzog C, Yang C. Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. Autophagy 2008; 4:710- 2; PMID:18497570
173. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 2009; 361:1570-83; PMID: 19828534; http://dx.doi.org/10.1056/NEJMra0901217
174. Belibi FA, Edelstein CL. Novel targets for the treatment of autosomal dominant polycystic kidney disease. Expert Opin Investig Drugs 2010; 19: 315-28; PMID:20141351; http://dx.doi.org/10. 1517/13543781003588491
175. Shillingford JM, Murcia NS, Larson CH, Low SH, Hedgepeth R, Brown N, et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A 2006; 103:5466-71; PMID:16567633; http://dx.doi.org/10.1073/pnas.0509694103
176. Weimbs T. Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? Cell Cycle 2006; 5:2425-9; PMID:17102641; http://dx. doi.org/10.4161/cc.5.21.3408
177. Wu M, Wahl PR, Le Hir M, Wackerle-Men Y, Wuthrich RP, Serra AL. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease. Kidney Blood Press Res 2007; 30:253-9; PMID:17596700; http:// dx.doi.org/10.1159/000104818
178. Tao Y, Kim J, Schrier RW, Edelstein CL. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol 2005; 16:46-51; PMID:15563559; http://dx.doi.org/10. 1681/ASN.2004080660
179. Zafar I, Ravichandran K, Belibi FA, Doctor RB, Edelstein CL. Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease. Kidney Int 2010; 78:754-61; PMID:20686448; http://dx.doi.org/10. 1038/ki.2010.250
180. Shillingford JM, Piontek KB, Germino GG, Weimbs T. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J Am Soc Nephrol 2010; 21:489-97; PMID:20075061; http://dx.doi.org/ 10.1681/ASN.2009040421
181. Korolchuk VI, Rubinsztein DC. Regulation of autophagy by lysosomal positioning. Autophagy 2011; 7:927-8; PMID:21521941; http://dx.doi.org/10. 4161/auto.7.8.15862
182. Walz G, Budde K, Mannaa M, Nürnberger J, Wanner C, Sommerer C, et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2010; 363:830-40; PMID:20581392; http:// dx.doi.org/10.1056/ NEJMoa1003491
183. Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 2010; 363:820-9; PMID:20581391; http://dx. doi.org/10.1056/ NEJMoa0907419
184. Natoli TA, Smith LA, Rogers KA, Wang B, Komarnitsky S, Budman Y, et al. Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat Med 2010; 16:788-92; PMID:20562878; http:// dx.doi.org/10.1038/nm.2171
185. Belibi F, Ravichandran K, Zafar I, He Z, Edelstein CL. mTORC1/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease. Am J Physiol Renal Physiol 2011; 300:F236-44; PMID:20943770; http:// dx.doi.org/10.1152/ ajprenal.00129.2010
186. Chresta CM, Davies BR, Hickson I, Harding T, Cosulich S, Critchlow SE, et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res 2010; 70:288-98; PMID:20028854; http://dx.doi.org/ 10.1158/0008-5472.CAN-09-1751
187. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008; 4:151-75; PMID: 18188003
188. Cao Y, Klionsky DJ. Physiological functions of Atg6/ Beclin 1: a unique autophagy-related protein. Cell Res 2007; 17:839-49; PMID:17893711; http://dx.doi.org/ 10.1038/cr.2007.78
189. Ecder T, Melnikov VY, Stanley M, Korular D, Lucia MS, Schrier RW, et al. Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int 2002; 61:1220-30; PMID: 11918728; http://dx.doi.org/10.1046/ j.1523-1755. 2002.00250.x
190. Takakura A, Nelson EA, Haque N, Humphreys BD, Zandi-Nejad K, Frank DA, et al. Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Hum Mol Genet 2011; 20:4143-54; PMID:21821671; http://dx.doi.org/10. 1093/hmg/ddr338
191. Yu W, Kong T, Beaudry S, Tran M, Negoro H, Yanamadala V, et al. Polycystin-1 protein level determines activity of the Galpha12/JNK apoptosis pathway. J Biol Chem 2010; 285:10243-51; PMID:20106977; http://dx.doi.org/10. 1074/jbc.M109.070821
192. Høyer-Hansen M, Jäättelä M. AMP-activated protein kinase: a universal regulator of autophagy? Autophagy 2007; 3:381-3; PMID:17457036
193. Grimaldi C, Chiarini F, Tabellini G, Ricci F, Tazzari PL, Battistelli M, et al. AMP-dependent kinase/ mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. Leukemia 2011; PMID:21968881
194. Xie Z, He C, Zou MH. AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy. Autophagy 2011; 7:1254-5; PMID:21685727; http://dx.doi.org/10.4161/auto.7.10.16740
195. Takiar V, Nishio S, Seo-Mayer P, King JD, Jr., Li H, Zhang L, et al. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc Natl Acad Sci U S A 2011; 108:2462-7; PMID:21262823; http://dx.doi.org/10.1073/ pnas.1011498108
196. Parkhitko A, Myachina F, Morrison TA, Hindi KM, Auricchio N, Karbowniczek M, et al. Tumorigenesis in tuberous sclerosis complex is autophagy and p62/ sequestosome 1 (SQSTM1)-dependent. Proc Natl Acad Sci U S A 2011; 108:12455-60; PMID:21746920; http://dx.doi.org/10.1073/pnas.1104361108
197. Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008; 14:90-102; PMID:18598947; http://dx. doi.org/10.1016/j.ccr.2008.06. 004
198. El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9:527-35; PMID:19191769; http://dx.doi.org/10.1111/j.1600- 6143.2008.02519.x
199. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349:2326- 33; PMID:14668458; http://dx.doi.org/10.1056/ NEJMoa020009
200. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006; 81:643-54; PMID:16534463; http://dx.doi.org/10.1097/01.tp.0000190423.82154.01
201. Majmundar AJ, Wong WJ, Simon MC. Hypoxiainducible factors and the response to hypoxic stress. Mol Cell 2010; 40:294-309; PMID:20965423; http:// dx.doi.org/10.1016/j.molcel.2010.09.022
202. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469: 323-35; PMID:21248839; http://dx.doi.org/10.1038/ nature09782
203. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296:301-5; PMID:11951032; http://dx.doi.org/10.1126/science.1071059
204. Pallet N, Bouvier N, Bendjallabah A, Rabant M, Flinois JP, Hertig A, et al. Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death. Am J Transplant 2008; 8:2283-96; PMID:18785955; http://dx.doi.org/10. 1111/j.1600-6143.2008.02396.x
205. Lawson WE, Cheng DS, Degryse AL, Tanjore H, Polosukhin VV, Xu XC, et al. Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs. Proc Natl Acad Sci U S A 2011; 108:10562-7; PMID: 21670280; http://dx.doi.org/10. 1073/pnas.1107559108
206. Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, et al. Antioncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 2006; 8:1053-63; PMID:16964246; http://dx.doi.org/10.1038/ncb1471
207. Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 2008; 74:867-72; PMID:18633339; http://dx.doi.org/ 10.1038/ki.2008.350
208. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364:1814-27; PMID:15541456; http:// dx.doi.org/10.1016/S0140-6736(04)17406-0
209. Turkmen K, Martin J, Akcay A, Nguyen Q, Ravichandran K, Faubel S, et al. Apoptosis and autophagy in cold preservation ischemia. Transplantation 2011; 91:1192-7; PMID:21577181; http://dx.doi.org/10.1097/TP.0b013e31821ab9c8
210. Zhu C, Wang X, Xu F, Bahr BA, Shibata M, Uchiyama Y, et al. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 2005; 12:162-76; PMID:15592434; http://dx.doi.org/10.1038/sj.cdd. 4401545
211. Gotoh K, Lu Z, Morita M, Shibata M, Koike M, Waguri S, et al. Participation of autophagy in the initiation of graft dysfunction after rat liver transplantation. Autophagy 2009; 5:351-60; PMID: 19158494; http://dx.doi.org/10.4161/auto.5.3.7650
212. Lu Z, Dono K, Gotoh K, Shibata M, Koike M, Marubashi S, et al. Participation of autophagy in the degeneration process of rat hepatocytes after transplantation following prolonged cold preservation. Arch Histol Cytol 2005; 68:71-80; PMID:15827380; http://dx.doi.org/10.1679/aohc.68.71
213. Pallet N, Thervet E, Legendre C, Anglicheau D. Sirolimus early graft nephrotoxicity: clinical and experimental data. Curr Drug Saf 2006; 1:179-87; PMID:18690929; http://dx.doi.org/10.2174/ 157488606776930580
214. Thaunat O, Beaumont C, Chatenoud L, Lechaton S, Mamzer-Bruneel MF, Varet B, et al. Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state. Transplantation 2005; 80:1212-9; PMID:16314788; http://dx.doi.org/10.1097/01.tp.0000179106.07382.6a
215. Powell JD, Delgoffe GM. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 2010; 33:301-11; PMID: 20870173; http://dx.doi.org/10.1016/j.immuni.2010. 09.002
216. Säemann MD, Haidinger M, Hecking M, Hörl WH, Weichhart T. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant 2009; 9:2655-61; PMID: 19788500; http://dx.doi.org/10. 1111/j.1600-6143. 2009.02832.x
217. Beljanski V, Knaak C, Smith CD. A novel sphingosine kinase inhibitor induces autophagy in tumor cells. J Pharmacol Exp Ther 2010; 333:454-64; PMID: 20179157; http://dx.doi.org/10.1124/jpet.109.163337
218. Chaigne-Delalande B, Guidicelli G, Couzi L, Merville P, Mahfouf W, Bouchet S, et al. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal. J Immunol 2008; 181:7630-8; PMID:19017951
219. Simons M, Hartleben B, Huber TB. Podocyte polarity signalling. Curr Opin Nephrol Hypertens 2009; 18:324-30; PMID:19542980; http://dx.doi.org/10. 1097/MNH.0b013e32832e316d
220. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007; 71:1205-14; PMID:17410103; http://dx.doi.org/10. 1038/sj.ki.5002222
221. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16:2941-52; PMID:16107576; http://dx.doi. org/10.1681/ASN.2005010055
222. Pavenstädt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83:253-307; PMID:12506131
223. Sato S, Adachi A, Sasaki Y, Dai W. Autophagy by podocytes in renal biopsy specimens. J Nihon Med Sch 2006; 73:52-3; PMID:16641527; http://dx.doi.org/ 10.1272/jnms.73.52
224. Sato S, Yanagihara T, Ghazizadeh M, Ishizaki M, Adachi A, Sasaki Y, et al. Correlation of autophagy type in podocytes with histopathological diagnosis of IgA nephropathy. Pathobiology 2009; 76:221-6; PMID: 19816081; http://dx.doi.org/10.1159/000228897
225. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia- Arencibia M, Green-Thompson ZW, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010; 90:1383-435; PMID: 20959619; http://dx.doi.org/10.1152/physrev.00030. 2009
226. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007; 13:619-24; PMID:17450150; http://dx.doi.org/ 10.1038/nm1574
227. Anderson S, Brenner BM. The aging kidney: structure, function, mechanisms, and therapeutic implications. J Am Geriatr Soc 1987; 35:590-3; PMID:3553292
228. Floege J, Hackmann B, Kliem V, Kriz W, Alpers CE, Johnson RJ, et al. Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int 1997; 51:230-43; PMID: 8995738; http://dx.doi.org/10.1038/ki.1997.28
229. Kaplan C, Pasternack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80:227-34; PMID:51591
230. McCray BA, Taylor JP. The role of autophagy in age-related neurodegeneration. Neurosignals 2008; 16: 75-84; PMID:18097162; http://dx.doi.org/10.1159/ 000109761
231. Riediger F, Quack I, Qadri F, Hartleben B, Park JK, Potthoff SA, et al. Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol 2011; 22:2193-202; PMID:22034640; http://dx.doi. org/10.1681/ASN. 2011020200
232. Fischer EG, Moore MJ, Lager DJ. Fabry disease: a morphologic study of 11 cases. Mod Pathol 2006; 19:1295-301; PMID:16799480; http://dx.doi.org/10. 1038/modpathol.3800634
233. Kobayashi H, Takahashi-Fujigasaki J, Fukuda T, Sakurai K, Shimada Y, Nomura K, et al. Pathology of the first autopsy case diagnosed as mucolipidosis type III α/β suggesting autophagic dysfunction. Mol Genet Metab 2011; 102:170-5; PMID:21051253; http://dx.doi.org/10.1016/j.ymgme.2010.09.014
234. Servais A, Morinière V, Grünfeld JP, Noël LH, Goujon JM, Chadefaux-Vekemans B, et al. Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping. Clin J Am Soc Nephrol 2008; 3:27-35; PMID:18178779; http://dx.doi.org/ 10.2215/CJN.01740407
235. Kashtan CE, Nevins TE, Posalaky Z, Vernier RL, Fish AJ. Proteinuria in a child with sialidosis: case report and histological studies. Pediatr Nephrol 1989; 3:166-74; PMID:2701867; http://dx.doi.org/10.1007/ BF00852901
236. Santoro D, Rosenbloom BE, Cohen AH. Gaucher disease with nephrotic syndrome: response to enzyme replacement therapy. Am J Kidney Dis 2002; 40:E4; PMID:12087590; http://dx.doi.org/10.1053/ajkd. 2002.33935
237. Schiffmann R. Fabry disease. Pharmacol Ther 2009; 122:65-77; PMID:19318041; http://dx.doi.org/10. 1016/j.pharmthera.2009.01.003
238. Chévrier M, Brakch N, Céline L, Genty D, Ramdani Y, Moll S, et al. Autophagosome maturation is impaired in Fabry disease. Autophagy 2010; 6:589- 99; PMID:20431343; http://dx.doi.org/10.4161/auto. 6.5.11943
239. Korolchuk VI, Mansilla A, Menzies FM, Rubinsztein DC. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell 2009; 33:517-27; PMID:19250912; http://dx.doi.org/ 10.1016/j.molcel. 2009.01.021
240. Sever S, Altintas MM, Nankoe SR, Möller CC, Ko D, Wei C, et al. Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest 2007; 117:2095-104; PMID:17671649; http://dx.doi.org/10.1172/JCI32022
241. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008; 14:931- 8; PMID:18724379; http://dx.doi.org/10.1038/nm. 1857
242. Yaddanapudi S, Altintas MM, Kistler AD, Fernandez I, Möller CC, Wei C, et al. CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest 2011; 121:3965-80; PMID:21911934; http://dx.doi.org/10.1172/JCI58552
243. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841-5; PMID: 20647424; http://dx.doi.org/10.1126/ science.1193032
244. Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Hu CA. Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J Biol Chem 2008; 283:21540-9; PMID:18505729; http://dx.doi.org/10. 1074/jbc. M800214200
245. Cuervo AM. Autophagy and aging: keeping that old broom working. Trends Genet 2008; 24:604-12; PMID:18992957; http://dx.doi.org/10.1016/j.tig. 2008.10.002
246. Cuervo AM, Dice JF. Age-related decline in chaper-one- mediated autophagy. J Biol Chem 2000; 275:31505-13; PMID:10806201; http://dx.doi.org/ 10.1074/jbc.M002102200
247. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-47; PMID: 17986697; http://dx.doi.org/10.1001/jama.298.17. 2038
248. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011; 57 (Suppl 1):A8; PMID:21184928; http://dx.doi.org/10. 1053/j.ajkd.2010.10.007
249. Chronopoulos A, Cruz DN, Ronco C. Hospitalacquired acute kidney injury in the elderly. Nat Rev Nephrol 2010; 6:141-9; PMID:20125094; http://dx. doi.org/10.1038/nrneph.2009.234
250. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13:621-30; PMID:19513802; http://dx.doi.org/ 10.1007/s10157-009-0199-x
251. Schmitt R, Cantley LG. The impact of aging on kidney repair. Am J Physiol Renal Physiol 2008; 294: F1265-72; PMID:18287400; http://dx.doi.org/10. 1152/ajprenal.00543.2007
252. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13:3005-15; PMID:12444221; http://dx.doi.org/10. 1097/01.ASN.0000039661.06947.FD
253. Christensen EI, Nielsen S. Structural and functional features of protein handling in the kidney proximal tubule. Semin Nephrol 1991; 11:414-39; PMID: 1947495
254. Kume S, Uzu T, Horiike K, Chin-Kanasaki M, Isshiki K, Araki S, et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest 2010; 120:1043-55; PMID:20335657; http:// dx.doi.org/10.1172/JCI41376
255. Cui J, Bai X-Y, Shi S, Cui S, Hong Q, Cai G, et al. Age-related changes in the function of autophagy in rat kidneys. Age (Omaha) 2011; 34:329-39; http://dx.doi. org/10.1007/s11357-011-9237-1
256. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325:201-4; PMID:19590001; http:// dx.doi.org/10.1126/science. 1173635
257. Guarente L, Picard F. Calorie restriction-the SIR2 connection. Cell 2005; 120:473-82; PMID: 15734680; http://dx.doi.org/10.1016/j.cell.2005.01. 029
258. McKiernan SH, Tuen VC, Baldwin K, Wanagat J, Djamali A, Aiken JM. Adult-onset calorie restriction delays the accumulation of mitochondrial enzyme abnormalities in aging rat kidney tubular epithelial cells. Am J Physiol Renal Physiol 2007; 292:F1751-60; PMID:17344189; http://dx.doi.org/10.1152/ajprenal. 00307.2006
259. Wiggins JE, Goyal M, Sanden SK, Wharram BL, Shedden KA, Misek DE, et al. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 2005; 16:2953-66; PMID:16120818; http:// dx.doi.org/10.1681/ASN.2005050488
260. Mimura I, Nangaku M. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol 2010; 6:667-78; PMID:20877304; http://dx.doi.org/10.1038/nrneph.2010.124
261. Samokhvalov V, Scott BA, Crowder CM. Autophagy protects against hypoxic injury in C. elegans. Autophagy 2008; 4:1034-41; PMID:18849662
262. Hars ES, Qi H, Ryazanov AG, Jin S, Cai L, Hu C, et al. Autophagy regulates ageing in C. elegans. Autophagy 2007; 3:93-5; PMID:17204841
263. Jia K, Levine B. Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy 2007; 3:597-9; PMID:17912023
264. Meléndez A, Tallóczy Z, Seaman M, Eskelinen E-L, Hall DH, Levine B. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003; 301:1387-91; PMID:12958363; http:// dx.doi.org/10.1126/science.1087782
265. De Meyer GR, De Keulenaer GW, Martinet W. Role of autophagy in heart failure associated with aging. Heart Fail Rev 2010; 15:423-30; PMID:20383579; http://dx.doi.org/10.1007/s10741-010-9166-6
266. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, et al. Autophagy is required to maintain muscle mass. Cell Metab 2009; 10:507-15; PMID:19945408; http://dx.doi.org/10.1016/j.cmet. 2009.10.008
267. Zhang C, Cuervo AM. Restoration of chaperonemediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat Med 2008; 14:959-65; PMID:18690243; http://dx.doi.org/10. 1038/nm.1851
268. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8:445-544; http://dx. doi.org/10.4161/ auto.19496